Adam Bonder, MD, MBA, is the Medical Director of Clinova Solutions and a board-certified physician with 15 years of experience specializing in recurrent UTI diagnosis, chronic urinary tract infections, and lower urinary tract symptoms (LUTS) across adult and pediatric populations. His clinical expertise in recurrent urinary infection patterns, advanced diagnostics, and individualized treatment planning anchors Clinova's evidence-based standard of care.

At Clinova, Dr. Bonder's work centers on moving patients out of chronic UTI cycles and toward lasting resolution. By applying precision diagnostic frameworks, antibiotic stewardship, and prevention-based treatment strategies, he ensures every patient evaluation is grounded in medical rigor and guided by outcomes designed for long-term urinary health. His experience across complex and treatment-resistant UTI cases brings a depth of diagnostic clarity for recurrent UTI patients.

Dr. Bonder's approach reflects Clinova's foundational mission: to deliver care that goes beyond the prescription pad. Through systematic clinical evaluation, urinary microbiome analysis, and a commitment to understanding the full picture of each patient's recurrent bladder infections and chronic urinary symptoms, he helps bridge the gap between persistent symptoms and accurate, actionable diagnoses. His prevention-first philosophy supports Clinova's broader commitment to reducing antibiotic dependency, improving diagnostic accuracy, and building individualized treatment protocols that address the root causes of recurrent UTI rather than masking them.

For patients with chronic UTI, recurring bladder infections, persistent pelvic symptoms, or a history of failed antibiotic treatment, Dr. Bonder's clinical leadership ensures that Clinova's telehealth platform delivers the medical oversight, diagnostic precision, and evidence-based chronic UTI treatment that this underserved patient population deserves.